Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 févr. 2023 08h00 HE | Source: PharmAla Biotech

PharmAla Biotech Closes Purchase Order With Emyria Ltd., Completes Filing of “LaNeo” Trademark in Australia

VANCOUVER, British Columbia, Feb. 14, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that, in the wake of a landmark decision by the...
03 févr. 2023 11h54 HE | Source: Visiongain Reports Ltd

Allergic rhinitis drugs market is projected to grow at a CAGR of 3.78% by 2033: Visiongain Reports Ltd

Visiongain has published a new report entitled Allergic Rhinitis Drugs Market Report 2023-2033. It includes profiles of Allergic Rhinitis Drugs Market and Forecasts, Market Segment by Size by...
03 févr. 2023 00h01 HE | Source: PharmAla Biotech

Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change

VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
02 févr. 2023 09h30 HE | Source: Persistence Market Research

High Potency Active Pharmaceutical Ingredients Market to Reach a Revenue of Around US$ 23.3 Billion by the End of 2023 at a CAGR of 11.1%, States Persistence Market Research

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The High-potency pharmaceutical active ingredients market revenues were estimated at US$ 21.2 Billion in 2022 and is anticipated to grow at a CAGR of...
24 janv. 2023 08h50 HE | Source: PharmAla Biotech

PharmAla Biotech granted an Export Permit for 300 grams of LaNeo™ MDMA

VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE: MDMA), a biotechnology company focused on the research, development, and...
17 janv. 2023 04h33 HE | Source: Douglas Insights

Pharmaceutical Drugs Market by 2022-2027 | Demand, Trends, Opportunities, Challenges, Risks Factors Analysis, Competitive Situation | Key Players, Types, Applications, Regional Analysis

Douglas, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drugs Industry takes the initiative in research, development, production, and the consequent distribution of drugs all over the world....
16 janv. 2023 09h00 HE | Source: Sash Windows

Sash Windows Offers High-Quality Secondary Glazing On A Range Of Different Window Types To Help Homeowners Save Energy This Winter As Costs Continue To Soar

London, UK, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Sash Windows is an award-winning, multi-business accredited secondary glazing maintenance, repair and installation firm that has been offering a...
04 janv. 2023 08h30 HE | Source: Dyadic International, Inc.

Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference

JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
30 déc. 2022 08h03 HE | Source: US Capital Global

US Capital Expands London Office with Appointment of Managing Director Prodi Bhattacharya

San Francisco, California, USA, Dec. 30, 2022 (GLOBE NEWSWIRE) -- US Capital is pleased to announce that Prodi Bhattacharya, Ph.D., has joined the group as a Managing Director at US Capital’s...
21 déc. 2022 09h00 HE | Source: Knowledge Train

Knowledge Train Starts Offering Its First Post-Pandemic Face-To-Face PRINCE2 Training Courses At Its London Training Centre

London, UK, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Knowledge Train is a leading provider of project management training and certification in the UK and, since 2005, has helped tens of thousands of people...

Page précédente